A significant breakthrough in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in several forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research